Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Promise Bio
Promise Bio secures $8.3M in seed investment for immune-mediated diseases
By
Anthony Vecchione
|
11:17 am |
December 19, 2024
The company will use the funds to increase the development of its computational platform to predict patient treatment responses and support drug research & development.
